Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer

Cancer Medicine(2020)10.1002/cam4.3078Source: DataRank Database

Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer is a research paper published in Cancer Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.76)OA: goldTopics (68)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Lin Li ORCID,Paul J. Yazaki ORCID,Junie Chea,Erasmus Poku,David Colcher ORCID

Live enrichment

PubMed:32368864 OpenAlex:https://openalex.org/W3023552131

National Cancer Institute

Grant: P30CA033572

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

FWCI

0.76

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.3078

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cam4.3078

publisherhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcam4.3078

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3078

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/cam4.3078

Fields of Study

HER2/EGFR in Cancer ResearchOvarian cancer diagnosis and treatmentMonoclonal and Polyclonal Antibodies Research03 medical and health sciences0302 clinical medicineAcetatesAnimalsAntibodies, NeoplasmAntigens, NeoplasmCell Line, TumorFemaleHT29 CellsHumansImmunoconjugatesImmunologic FactorsMiceOligopeptidesOvarian NeoplasmsPositron-Emission TomographyRandom AllocationSulfones

MeSH Terms

AcetatesAnimalsAntibodies, NeoplasmAntigens, NeoplasmFemaleHumansImmunologic FactorsOligopeptidesOvarian NeoplasmsRandom AllocationSulfonesImmunoconjugatesHT29 CellsCell Line, TumorPositron-Emission TomographyMice

Keywords

Ovarian cancerMedicineAntibodyConjugateMonoclonal antibodyAntibody-drug conjugateCancerInternal medicineCancer researchImmunologyTAG72Ovarian NeoplasmsImmunoconjugatesAntibodies, NeoplasmNeoplasms. Tumors. Oncology. Including cancer and carcinogensAcetatesMiceRandom AllocationAntigens, NeoplasmCell Line, TumorPositron-Emission TomographyAnimalsHumansImmunologic Factorsantibody drug conjugateFemaleSulfonesHT29 CellsOligopeptidesRC254-282Cancer Biology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being